Literature DB >> 22312091

Reports of increased mortality and GH: will this affect current clinical practice?

Saul Malozowski.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22312091      PMCID： PMC3275356          DOI： 10.1210/jc.2011-3363

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  11 in total

1.  Increased mortality associated with growth hormone treatment in critically ill adults.

Authors:  J Takala; E Ruokonen; N R Webster; M S Nielsen; D F Zandstra; G Vundelinckx; C J Hinds
Journal:  N Engl J Med       Date:  1999-09-09       Impact factor: 91.245

2.  Reevaluating erythropoiesis-stimulating agents.

Authors:  Paul L Kimmel; Saul Malozowski
Journal:  N Engl J Med       Date:  2010-05-06       Impact factor: 91.245

Review 3.  Medical progress: Acromegaly.

Authors:  Shlomo Melmed
Journal:  N Engl J Med       Date:  2006-12-14       Impact factor: 91.245

4.  Erythropoiesis-stimulating agents--time for a reevaluation.

Authors:  Ellis F Unger; Aliza M Thompson; Melanie J Blank; Robert Temple
Journal:  N Engl J Med       Date:  2010-01-06       Impact factor: 91.245

Review 5.  Psychosocial aspects of short stature and its management: good deeds require good science.

Authors:  David E Sandberg
Journal:  Horm Res Paediatr       Date:  2011-09-07       Impact factor: 2.852

6.  Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study.

Authors:  Jean-Claude Carel; Emmanuel Ecosse; Fabienne Landier; Djamila Meguellati-Hakkas; Florentia Kaguelidou; Grégoire Rey; Joël Coste
Journal:  J Clin Endocrinol Metab       Date:  2012-01-11       Impact factor: 5.958

7.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

8.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

Review 9.  Review of 64 cases of death in children with Prader-Willi syndrome (PWS).

Authors:  M Tauber; G Diene; C Molinas; M Hébert
Journal:  Am J Med Genet A       Date:  2008-04-01       Impact factor: 2.802

10.  Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor.

Authors:  Berrin Ergun-Longmire; Ann C Mertens; Pauline Mitby; Jing Qin; Glenn Heller; Weiji Shi; Yutaka Yasui; Leslie L Robison; Charles A Sklar
Journal:  J Clin Endocrinol Metab       Date:  2006-07-05       Impact factor: 6.134
View more
  5 in total

Review 1.  Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.

Authors:  Anna Petryk; Roopa Kanakatti Shankar; Neelam Giri; Anthony N Hollenberg; Meilan M Rutter; Brandon Nathan; Maya Lodish; Blanche P Alter; Constantine A Stratakis; Susan R Rose
Journal:  J Clin Endocrinol Metab       Date:  2015-01-09       Impact factor: 5.958

2.  Growth Hormone and Treatment Controversy; Long Term Safety of rGH.

Authors:  Sara A Divall; Sally Radovick
Journal:  Curr Pediatr Rep       Date:  2013-06-01

3.  Early diagnosis and treatment referral of children born small for gestational age without catch-up growth are critical for optimal growth outcomes.

Authors:  Christopher P Houk; Peter A Lee
Journal:  Int J Pediatr Endocrinol       Date:  2012-05-04

Review 4.  GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome.

Authors:  Cheri L Deal; Michèle Tony; Charlotte Höybye; David B Allen; Maïthé Tauber; Jens Sandahl Christiansen
Journal:  J Clin Endocrinol Metab       Date:  2013-03-29       Impact factor: 5.958

5.  Gamma-Aminobutyric Acid (GABA) Promotes Growth in Zebrafish Larvae by Inducing IGF-1 Expression via GABAA and GABAB Receptors.

Authors:  Athapaththu Mudiyanselage Gihan Kavinda Athapaththu; Ilandarage Menu Neelaka Molagoda; Rajapaksha Gedara Prasad Tharanga Jayasooriya; Yung Hyun Choi; You-Jin Jeon; Joung-Hyun Park; Bae-Jin Lee; Gi-Young Kim
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.